Showing 161 - 180 of 512 results
An initiative for National Science Week 2024 the Shorebirds Competition addresses the 2024 theme for National Science Week, ‘Species Survival’ and provides unique cross-curricula learning for Australian primary students in Years 3 to 6.
State- of-the-art microdosimeters used in research
A group from Monash university has sought to make a new innovative nano-porous sieve material which has the potential to be produced on a global scale and is effective for a much longer time.
ANSTO’s user office in Melbourne offers access to the Australian Synchrotron, a world-class research facility with over 4,000 user visits per year. ANSTO seeks collaboration and partnerships with research organisations, scientific users and commercial users.
The Chair of ANSTO, The Hon Dr Annabelle Bennett, AC SC, announced today that Mr Shaun Jenkinson has been reappointed as the Chief Executive Officer of ANSTO.
Launch of the second phase of construction of the underground laboratory to detect dark matter.
Nuclear power is used as a reliable and clean energy solution in most OECD countries and many other parts of the world. Although it is banned in Australia, a number of government reviews are looking at current prohibitions on nuclear power.
The final report on the safety of Building 23 by the independent expert review team has been completed.
The Biological Small Angle X-ray Scattering beamline will be optimised for measuring small angle scattering of surfactants, nanoparticles, polymers, lipids, proteins and other biological macromolecules in solution. BioSAXS combines combine a state-of-the-art high-flux small angle scattering beamline with specialised in-line protein purification and preparation techniques for high-throughput protein analysis.
The Detection & Imaging group builds on ANSTO’s 70-year history of scientific achievements and contributions in meeting the nuclear needs of industry, globally.
Nuclear security experts and officials from Australia’s nuclear agencies have convened at the International Atomic Energy Agency’s (IAEA) headquarters in Vienna, Austria last week for the International Conference on Nuclear Security (ICONS).
The nuclear medicine community has welcomed the Australian Government’s decision to provide $30 million in funding to ANSTO for the design of a new nuclear medicine manufacturing facility.
